Results 171 to 180 of about 333,354 (320)
Clinical implications of imlifidase interference in antibody screening and transfusion management
Abstract Background Imlifidase has received conditional approval from the EMA for desensitizing deceased donor kidney transplant recipients. It works by cleaving IgG into F(ab′)2 and Fc fragments, thereby reducing the risk of antibody‐mediated rejection. However, its impact on diagnostic assays remains understudied. Case Report We present the case of a
Zgjim Osmani +2 more
wiley +1 more source
Abstract Background Restrictive red blood cell transfusion strategies are widely recommended for acute anemia but may not adequately address the needs of chronically anemic patients with transfusion‐dependent myelodysplastic syndromes or myeloproliferative neoplasms.
Rik P. B. Tonino +5 more
wiley +1 more source
Determination of the erythrocyte sedimentation rate using the hematocrit-corrected aggregation index and mean corpuscular volume. [PDF]
Higuchi M, Watanabe N.
europepmc +1 more source
Abstract Background Extremely preterm neonates often require red blood cell (RBC) transfusions derived from adult donors. These transfusions introduce adult hemoglobin into a neonatal hematopoietic system dominated by fetal hemoglobin (HbF), shifting the oxygen‐dissociation curve and increasing oxygen delivery to immature tissues.
Jip H. van Daelen +8 more
wiley +1 more source
Effect of dolutegravir on folate, vitamin B12 and mean corpuscular volume levels among children and adolescents with HIV: a sub-study of the ODYSSEY randomized controlled trial. [PDF]
Barlow-Mosha LN +33 more
europepmc +1 more source
MON-265 ANAEMIA, MEAN CORPUSCULAR VOLUME AND MORTALITY AMONG A BLACK CKD POPULATION IN SOUTH AFRICA
Aisha M. Nalado
openalex +1 more source
Crossed Erythrocytes Agglutination Pattern Observed in a Patient With Hereditary Elliptocytosis
International Journal of Laboratory Hematology, EarlyView.
Márcio A. W. Melo +3 more
wiley +1 more source
Abstract Background Cryoprecipitate Anti‐Haemophilic Factor (CRYO‐AHF) is enriched for fibrinogen, VWF, FVIII, FXIII and fibronectin, but has short post‐thaw expiration due to risk of transfusion‐transmitted infection (TTI) limiting availability for rapid treatment.
Florian Tupin +6 more
wiley +1 more source

